0 Bewertungen
ID

17250

Beschreibung

AVANDAMET Versus Metformin For Type 2 Diabetes Mellitus; ODM derived from: https://clinicaltrials.gov/show/NCT00241605

Link

https://clinicaltrials.gov/show/NCT00241605

Stichworte

Versionen (1)
  1. 02.09.16 02.09.16 -
Hochgeladen am

2. September 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

  • Neueste
  • Älteste
  • Beliebt
  • Neueste
    • Neueste
    • Älteste
    • Beliebt

    Keine Kommentare

    Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

    Eligibility Diabetes Mellitus, Type 2 NCT00241605

    Englisch

    Eligibility Diabetes Mellitus, Type 2 NCT00241605

    1 Formulare  
    Inclusion Criteria
    Beschreibung

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    patients between 18 and 75 years of age with type 2 diabetes mellitus and are currently on metformin monotherapy for glycemic control (100mg daily for at least 3 months prior to screening).
    Beschreibung

    Age | Diabetes Mellitus, Non-Insulin-Dependent | Metformin Glycaemia control

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0001779
    UMLS CUI [2]
    C0011860
    UMLS CUI [3,1]
    C0025598
    UMLS CUI [3,2]
    C3267174
    patients must have stopped previous treatment with thiazolidinediones or other anti-diabetic agents at least 3 months prior to screening.
    Beschreibung

    Thiazolidinediones stopped | Antidiabetics stopped

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C1257987
    UMLS CUI [1,2]
    C1272691
    UMLS CUI [2,1]
    C0935929
    UMLS CUI [2,2]
    C1272691
    women must be post-menopausal, surgically sterile or using acceptable contraceptive measures.
    Beschreibung

    Gender | Postmenopausal state | Female Sterilization | Contraceptive methods

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0079399
    UMLS CUI [2]
    C0232970
    UMLS CUI [3]
    C0015787
    UMLS CUI [4]
    C0700589
    Exclusion Criteria
    Beschreibung

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    prior history of hepatocellular reaction to or severe edema associated with the use of thiazolidinediones.
    Beschreibung

    HEPATOCELLULAR REACTION Thiazolidinediones Use | Severe edema Associated with Thiazolidinediones Use

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0518991
    UMLS CUI [1,2]
    C1257987
    UMLS CUI [1,3]
    C1524063
    UMLS CUI [2,1]
    C0341950
    UMLS CUI [2,2]
    C0332281
    UMLS CUI [2,3]
    C1257987
    UMLS CUI [2,4]
    C1524063
    have a known hypersensitivity to thiazolidinediones or biguanides.
    Beschreibung

    Hypersensitivity Thiazolidinediones | Hypersensitivity Biguanides

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0020517
    UMLS CUI [1,2]
    C1257987
    UMLS CUI [2,1]
    C0020517
    UMLS CUI [2,2]
    C0005382
    currently using insulin or any oral anti-diabetic agent other than metformin.
    Beschreibung

    Insulin | Oral hypoglycemic | Metformin

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0021641
    UMLS CUI [2]
    C0359086
    UMLS CUI [3]
    C0025598
    history of metabolic acidosis.
    Beschreibung

    Metabolic acidosis

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0220981
    history of substance abuse.
    Beschreibung

    Substance Use Disorders

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0038586
    have active cancer other than localized squamous or basal cell carcinoma.
    Beschreibung

    Malignant Neoplasms | Squamous cell carcinoma Localized | Basal cell carcinoma Localized

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0006826
    UMLS CUI [2,1]
    C0007137
    UMLS CUI [2,2]
    C0392752
    UMLS CUI [3,1]
    C0007117
    UMLS CUI [3,2]
    C0392752
    chronic disease requiring treatment with corticosteroids.
    Beschreibung

    Chronic disease Requirement Adrenal Cortex Hormones

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0008679
    UMLS CUI [1,2]
    C1514873
    UMLS CUI [1,3]
    C0001617
    other criteria will be evaluated at the screening visit.
    Beschreibung

    criteria Evaluation Screening

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0243161
    UMLS CUI [1,2]
    C1261322
    UMLS CUI [1,3]
    C0220908
    Zum Seitenanfang zurückkehren

    Ähnliche Modelle

    Eligibility Diabetes Mellitus, Type 2 NCT00241605

    1 Formulare
    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datentyp
    Alias
    Item Group
    C1512693 (UMLS CUI)
    Age | Diabetes Mellitus, Non-Insulin-Dependent | Metformin Glycaemia control
    Item
    patients between 18 and 75 years of age with type 2 diabetes mellitus and are currently on metformin monotherapy for glycemic control (100mg daily for at least 3 months prior to screening).
    boolean
    C0001779 (UMLS CUI [1])
    C0011860 (UMLS CUI [2])
    C0025598 (UMLS CUI [3,1])
    C3267174 (UMLS CUI [3,2])
    Thiazolidinediones stopped | Antidiabetics stopped
    Item
    patients must have stopped previous treatment with thiazolidinediones or other anti-diabetic agents at least 3 months prior to screening.
    boolean
    C1257987 (UMLS CUI [1,1])
    C1272691 (UMLS CUI [1,2])
    C0935929 (UMLS CUI [2,1])
    C1272691 (UMLS CUI [2,2])
    Gender | Postmenopausal state | Female Sterilization | Contraceptive methods
    Item
    women must be post-menopausal, surgically sterile or using acceptable contraceptive measures.
    boolean
    C0079399 (UMLS CUI [1])
    C0232970 (UMLS CUI [2])
    C0015787 (UMLS CUI [3])
    C0700589 (UMLS CUI [4])
    Item Group
    C0680251 (UMLS CUI)
    HEPATOCELLULAR REACTION Thiazolidinediones Use | Severe edema Associated with Thiazolidinediones Use
    Item
    prior history of hepatocellular reaction to or severe edema associated with the use of thiazolidinediones.
    boolean
    C0518991 (UMLS CUI [1,1])
    C1257987 (UMLS CUI [1,2])
    C1524063 (UMLS CUI [1,3])
    C0341950 (UMLS CUI [2,1])
    C0332281 (UMLS CUI [2,2])
    C1257987 (UMLS CUI [2,3])
    C1524063 (UMLS CUI [2,4])
    Hypersensitivity Thiazolidinediones | Hypersensitivity Biguanides
    Item
    have a known hypersensitivity to thiazolidinediones or biguanides.
    boolean
    C0020517 (UMLS CUI [1,1])
    C1257987 (UMLS CUI [1,2])
    C0020517 (UMLS CUI [2,1])
    C0005382 (UMLS CUI [2,2])
    Insulin | Oral hypoglycemic | Metformin
    Item
    currently using insulin or any oral anti-diabetic agent other than metformin.
    boolean
    C0021641 (UMLS CUI [1])
    C0359086 (UMLS CUI [2])
    C0025598 (UMLS CUI [3])
    Metabolic acidosis
    Item
    history of metabolic acidosis.
    boolean
    C0220981 (UMLS CUI [1])
    Substance Use Disorders
    Item
    history of substance abuse.
    boolean
    C0038586 (UMLS CUI [1])
    Malignant Neoplasms | Squamous cell carcinoma Localized | Basal cell carcinoma Localized
    Item
    have active cancer other than localized squamous or basal cell carcinoma.
    boolean
    C0006826 (UMLS CUI [1])
    C0007137 (UMLS CUI [2,1])
    C0392752 (UMLS CUI [2,2])
    C0007117 (UMLS CUI [3,1])
    C0392752 (UMLS CUI [3,2])
    Chronic disease Requirement Adrenal Cortex Hormones
    Item
    chronic disease requiring treatment with corticosteroids.
    boolean
    C0008679 (UMLS CUI [1,1])
    C1514873 (UMLS CUI [1,2])
    C0001617 (UMLS CUI [1,3])
    criteria Evaluation Screening
    Item
    other criteria will be evaluated at the screening visit.
    boolean
    C0243161 (UMLS CUI [1,1])
    C1261322 (UMLS CUI [1,2])
    C0220908 (UMLS CUI [1,3])
    Zum Seitenanfang zurückkehren 

    Hilfe

    Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

    Zum Video